Finzati - Logo
CLSD logo

Clearside Biomedical, Inc.

CLSD • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.15M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 4.44Negative growth trendWeak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 14, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.15M
52W Range0.31 - 17.10
Beta1.79
Gross Margin91.05%
Oper. Margin-17.36%
Profit Margin-20.64%
Debt/Eq-1.35
Current Ratio4.44
Quick Ratio4.44
Volume2.05M

Investment DNA

How strong this company looks for long-term investors

28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 4.44Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/2/2016
Industry: Biotechnology
P/B i: -1.80
Debt / Equity i: -1.35
Operating Margin: -1735.70%
Net Margin: -2064.42%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: -1.35
Current Ratio: 4.44
Quick Ratio: 4.44
Status: Good

Insider Transactions

Recent executive and insider activity

WHITMORE BRADFORD T
Transaction: 08/13/2020
BUY
Change
+50,000
Price
$1.65
Filing
08/13/2020
Type
BUY
WHITMORE BRADFORD T
Transaction: 08/12/2020
BUY
Change
+300,000
Price
$1.63
Filing
08/13/2020
Type
BUY